EN
HI
Piramal Pharma Chart
Piramal Pharma Share Key Metrics
Volume
27.97 L
Market Cap
23441.29 CR
LTQ@LTP
15@176.35
ATP
174.51
Var Margin
18.77 %
Circuit Range
138.59-207.87
Delivery %
34.26 %
Value
48.81 CR
ASM/GSM
No
Market Lot
1
Summary
Piramal Pharma share price is ₹176.35 as of 20 May, 2026. The stock Piramal Pharma intraday movement has stayed between ₹170.20 and ₹177.00, while on a 52-week basis,Piramal Pharma price 52 week high is ₹226.00 & its 52 week low is ₹132.30.
In terms of trading activity, Piramal Pharma has recorded a volume of 2796890 shares, The Piramal Pharma has a market cap of ₹1329248130 CR. The stock’s Average Traded Price (ATP) stands at ₹174.51, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15 @ ₹176.35.
Piramal Pharma operates within a circuit range of ₹138.59 – ₹207.87, with a Value of ₹48.81 CR. The Delivery Percentage for the day is 34.26%. Additionally, Piramal Pharma currently falls under the No framework, and trades with a market lot size of 1.
Piramal Pharma Fundamentals
View MoreP/E Ratio
0
P/B Ratio
2.82
Div. Yield
0
Sector P/E
71.7
Sector P/B
3.51
Sec. Div. Yield
0.56
Piramal Pharma Resistance and Support
Pivot 174.82
Resistance
First Resistance
177.32
Second Resistance
181.4
Third Resistance
183.9
Support
First Support
170.74
Second Support
168.24
Third Support
164.16
Piramal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-04-28 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
Piramal Pharma News
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Piramal Pharma is scheduled to hold several analyst and institutional investor meetings from late May to mid-June 2026. These meetings will involve major financial institutions, providing a platform for investor engagement.
May 19 2026 14:05:00
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Successful Closure Of US FDA Inspection At Piramal Pharma'S Manufacturing Facility Located At Digwal, Telangana, India
Piramal Pharma's manufacturing facility in Digwal, Telangana, has successfully completed its US FDA inspection, with the US FDA issuing an Establishment Inspection Report (EIR). This closure removes regulatory uncertainty and ensures continued production.
May 18 2026 11:05:00
Read More
About Piramal Pharma
NSE : 11571
BSE : 543635
ISIN : INE0DK501011
Piramal Pharma Management
| Name | Position |
|---|---|
| Nandini Piramal | Chairperson |
| Maneesh Sharma | Company Secretary and Compliance Officer |
Piramal Pharma Similar Stocks
Emcure Pharmaceuticals Ltd.
1734.00
23.80 (1.39%)
Krishna Institute of Medical Sciences Ltd
755.80
14.75 (1.99%)
Dr. Lal Pathlabs Ltd.
1668.60
-35.10 (2.06%)
Wockhardt Ltd.
1611.90
-8.30 (0.51%)
Sai Life Sciences Ltd.
1141.30
15.90 (1.41%)
Acutaas Chemicals Ltd.
2880.60
-5.90 (0.20%)
Pfizer Ltd.
4687.60
-97.80 (2.04%)
Neuland Laboratories Ltd.
16624.00
-166.00 (0.99%)
Natco Pharma Ltd.
1156.30
25.40 (2.25%)
Onesource Specialty Pharma Ltd.
1867.40
12.90 (0.70%)
Piramal Pharma FAQs
The Buying Price of Piramal Pharma share is 176.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Piramal Pharma shares is 2.82. Useful to assess the stock's value relative to its book value.
To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 71.7 & 3.51 with sector averages, along with growth rates and financial metrics.
The Market Cap of Piramal Pharma is 23441.29 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Piramal Pharma share price is 226.00 & 132.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Piramal Pharma belongs to the Healthcare sector.
